All In Biotech

Drug Trial Radar · NCT05623540

Bisphosphonates Use After Total Joint Arthroplasty

Postoperative Use of Bisphosphonates Reduces Adverse Outcome After Primary Total Joint Arthroplasty: A Nationwide Population-based Cohort Study

Last checked: Nov 19, 2026Latest source record: Nov 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

27,405

Actual

Start

Jan 1, 2000

Primary completion

Dec 31, 2015

Study completion Nov 2, 2022

Sponsor

Lead sponsor
National Defense Medical Center, TaiwanAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 21, 2022

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 40 years

Summary

As written by the sponsor on the registry.

Background Bisphosphonates has been associated with a decreased risk of revision total joint replacements because of its effects on decreased periprosthetic bone loss and prosthetic migration. However, the results in the early literature are inconsistent and the influence of bisphosphonates on associated complications and subsequent total joint arthroplasty (TJA) remains unknown. This study is to investigate the association between the use of bisphosphonates and risk of adverse outcomes after primary TJA. Materials and Methods This matched cohort study utilized National Health Insurance Research Database in Taiwan to identify patients who underwent primary TJA over a 15-year period (January 2000- December 2015 inclusive). Study participants were further categorized into two groups: bisphosphonates users and nonusers, using propensity score matching. The Kaplan-Meier curve analysis and adjusted hazard ratios (aHR) of revision surgery, adverse outcomes of primary surgery and undergoing subsequent TJA were calculated using Cox regression analysis.

Conditions

  • Diphosphonates

Interventions

  • Bisphosphonates, CombinationsDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. revision rate of joint arthroplastyTime frame: a 15-year period (January 2000- December 2015 inclusive)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tri-Service General Hospital, National Defense Medical Center

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.